Patients with a rare, chronic pain conditions such as primary erythromelalgia or paroxysmal extreme pain disorder exhibit gain of function mutations in SCN9A (8, 146, 160–163). The gene discussed is SCN9A; the disease is paroxysmal extreme pain disorder.